Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12301
Dawson Geophysical
DWSN
$103M
| $24K | ﹤0.01% |
16,421
+4,756
| +41% | +$6.47K |
|
12302
CALL
Achieve Life Sciences
ACHV
$841M
| $24K | ﹤0.01% |
+10,600
| New | +$30.2K |
|
12303
AgEagle Aerial Systems
UAVS
$67.9M
| $23.9K | ﹤0.01% |
23,168
| – | – |
|
12304
CALL
Wrap Technologies
WRAP
$94.5M
| $23.2K | ﹤0.01% |
14,900
+3,200
| +27% | +$4.82K |
|
|
DDL
12305
CALL
Dingdong
DDL
$505M
| $23.2K | ﹤0.01% |
+11,500
| New | +$26K |
|
|
HLVX
12306
DELISTED
HilleVax
HLVX
| $23.1K | ﹤0.01% |
11,606
-33,526
| -74% | -$61.3K |
|
12307
SmartRent
SMRT
$276M
| $23.1K | ﹤0.01% |
23,293
-210,991
| -90% | -$189K |
|
|
TOUR
12308
Tuniu
TOUR
$52.6M
| $23K | ﹤0.01% |
2,733
-651
| -19% | -$5.92K |
|
12309
Generation Income Properties
GIPR
$990K
| $22.8K | ﹤0.01% |
1,540
+214
| +16% | +$3.28K |
|
12310
Globus Maritime Ltd
GLBS
$82.7M
| $22.8K | ﹤0.01% |
19,816
-16,360
| -45% | -$18.7K |
|
12311
Citius Pharmaceuticals
CTXR
$16.6M
| $22.6K | ﹤0.01% |
+14,199
| New | +$13K |
|
12312
Bullfrog AI
BFRG
$10.8M
| $22.5K | ﹤0.01% |
14,923
+1,064
| +8% | +$1.81K |
|
12313
CALL
CEMIG Preferred Shares
CIG
$5.78B
| $22.1K | ﹤0.01% |
11,300
+600
| +6% | +$1.1K |
|
12314
CALL
C4 Therapeutics
CCCC
$517M
| $21.7K | ﹤0.01% |
15,200
-3,600
| -19% | -$5.24K |
|
|
MBAI
12315
Check-Cap
MBAI
$11.1M
| $21.7K | ﹤0.01% |
+3,940
| New | +$21.6K |
|
|
TOUR
12316
PUT
Tuniu
TOUR
$52.6M
| $21.7K | ﹤0.01% |
2,580
+670
| +35% | +$6.09K |
|
12317
PUT
Getty Images
GETY
$112M
| $21.6K | ﹤0.01% |
13,000
-93,700
| -88% | -$165K |
|
|
UBX
12318
DELISTED
Unity Biotechnology
UBX
| $21.6K | ﹤0.01% |
56,720
-6,016
| -10% | -$5.16K |
|
12319
PUT
Vivid Seats
SEAT
$81.9M
| $21.3K | ﹤0.01% |
+630
| New | +$27K |
|
|
12320
CALL
Citius Pharmaceuticals
CTXR
$16.6M
| $21.1K | ﹤0.01% |
+13,300
| New | +$12.2K |
|
|
TMQ
12321
PUT
Trilogy Metals
TMQ
$663M
| $21.1K | ﹤0.01% |
15,600
+4,800
| +44% | +$6.76K |
|
|
12322
PUT
Wrap Technologies
WRAP
$94.5M
| $20.9K | ﹤0.01% |
+13,400
| New | +$20.2K |
|
|
SVRN
12323
OceanPal Inc
SVRN
$15.6M
| $20.8K | ﹤0.01% |
+23
| New | +$11.2K |
|
|
HOOK
12324
CALL
DELISTED
HOOKIPA Pharma
HOOK
| $20.8K | ﹤0.01% |
+16,500
| New | +$20.4K |
|
12325
Vivani Medical
VANI
$128M
| $20.8K | ﹤0.01% |
16,114
+1,047
| +7% | +$1.15K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.